Company intelligence / Profile preview

Setrag

Salt Lake City, Utah, United Statessetrag.ga ↗

Ownership: Private
Development stage: Commercial

Overview

Sethera Therapeutics has developed a proprietary platform that bioengineers highly stable, controllable peptides, overcoming the traditional instability of peptide drugs. This enables the targeting of diseases previously considered "undruggable," such as certain cancers and genetic disorders. The company has secured $3 million in funding, established key academic collaborations with the University of Utah, and appointed Dr. Robert Langer as chair of its scientific advisory board. Clinical results are not yet available as programs remain preclinical or in early discovery phases[1].

Therapeutic areas: OncologyRare Diseases
Modalities: PeptidesBioengineered peptidesSmall molecule (as a broader category for peptides)
Industry: Biotech

Partnerships

University of Utah Chemistry Department (lab space/support)Industry partnerships for therapeutic co-development are mentioned but not named specifically

Beyond the preview

Go deeper on Setrag.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Setrag.

Explore the full profile